Retatrutide, from Soma, represents a exciting advance in weight management . This dual-action medication combines hormonal signaling activity with GIP pathway engagement, demonstrating remarkable efficacy in patient data for weight improvement. Scientists believe Retatrutide may provide a different solution for patients experiencing weight-related